Featured Publications

Arnold J, Acharya D, Boricha H, Chapagain H, Kainat A, Bradley A, Jeong J, Townsend KA, Ateya MB, DeMicco DA, Alish Y, Becich MJ,  Chuang CH, Fernandez SA, Ford DE, Hwang W, Kirchner HL, Morgan R, Paranjape A, Thomas NA, Williams DA, Hegeman-Dingle R, McLeod E, Saccone PA, McTigue KM.Real-world prescribing in accordance to ACC/AHA guidelines for lipid-lowering therapy in high-risk primary and secondary prevention of ASCVD: Real-World Prescribing for Lipid-Lowering Therapy. Am J Prev Card. 2025 Sept;23. doi: 10.1016/j.ajpc.2025.101067

Boyer AR, Friedman CP, Chuang CH, Hamm ME, Wyncott A, Merritt JG, Becich MJ, Fernandez SA, Ford DE, Kirchner HL, Parajape A, Williams DA, McTigue KM. The PaTH from discovery to implementation: Using a PCORnet® Clinical Research Network’s own research to prioritize topics for collaborative health improvement activities. Learn Health Sys. 2025;e70037. doi:10.1002/lrh2.70037

Hamm M, Wilson JD, Lee YJ, Norman N, Winstanley EL, McTigue KM. Substance use as subtext to health narratives: Identifying opportunities for improving care from community member perspectives. Patient Education and Counseling. Nov 2024(128). doi: 10.1016/j.pec.2024.108384.

Behari J, Bradley A, Townsend K, Becich MJ, Cappella N, Chuang CH, Fernandez SA, Ford DE, Kirchner HL, Morgan R, Paranjape A, Silverstein JC, Williams DA, Donahoo WT, Asrani SK, Ntanios F, Ateya M, Hegeman-Dingle R, McLeod E, McTigue K. Limitations of Noninvasive Tests-Based Population-Level Risk Stratification Strategy for Nonalcoholic Fatty Liver Disease. Dig Dis Sci. 2024 Feb;69(2):370-383. doi: 10.1007/s10620-023-08186-8. Epub 2023 Dec 7. PMID: 38060170.